Double-blind Comparison of Alprazolam, Diazepam, and Placebo for the Treatment of Negative Schizophrenic Symptoms
- 1 July 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 45 (7) , 655-659
- https://doi.org/10.1001/archpsyc.1988.01800310063008
Abstract
From JAMA Psychiatry — Double-blind Comparison of Alprazolam, Diazepam, and Placebo for the Treatment of Negative Schizophrenic SymptomsThis publication has 30 references indexed in Scilit:
- Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: Correlations to symptomatology and family historyPsychiatry Research, 1985
- The Two-syndrome Concept: Origins and Current StatusSchizophrenia Bulletin, 1985
- Treatment of Negative SymptomsSchizophrenia Bulletin, 1985
- Positive vs. Negative Schizophrenia: A Critical EvaluationSchizophrenia Bulletin, 1985
- Decreased Spinal Fluid Monoamine Metabolites and Norepinephrine in Schizophrenic Patients with Brain AtrophyPublished by Springer Nature ,1985
- Positive and negative symptoms in schizophreniaPsychiatry Research, 1984
- Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patientsPsychiatry Research, 1984
- Peptides, the limbic lobe and schizophreniaBrain Research, 1983
- Ventricular enlargement in schizophrenia: definition and prevalenceAmerican Journal of Psychiatry, 1982
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980